4//SEC Filing
Growth Equity Opportunities Fund IV, LLC 4
Accession 0001209191-22-054281
CIK 0001325879other
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 4:36 PM ET
Size
6.4 KB
Accession
0001209191-22-054281
Insider Transaction Report
Form 4
Growth Equity Opportunities IV, LLC
10% Owner
Transactions
- Other
Common Stock
2022-10-19−3,952,957→ 0 total
Footnotes (3)
- [F1]Growth Equity Opportunities Fund IV, LLC ("GEO IV") made a distribution of 3,952,957 shares of Common Stock of the Issuer to its sole member for no consideration on October 19, 2022.
- [F2]The Reporting Person previously over-reported one additional share of Common Stock of the Issuer due to rounding of fractional shares.
- [F3]The securities are directly held by GEO IV, and indirectly held by New Enterprise Associates 15, L.P. ("NEA 15"), the sole member of GEO IV, NEA Partners 15, L.P. ("NEA Partners 15"), the sole general partner of NEA 15, NEA 15 GP, LLC ("NEA 15 GP"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA 15, NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP (collectively, the "NEA 15 Managers"), together, the "GEO IV Indirect Reporting Persons"). The NEA 15 Managers are Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Scott D. Sandell and Peter W. Sonsini. The GEO IV Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities in which the GEO IV Indirect Reporting Persons have no pecuniary interest.
Documents
Issuer
AVEO PHARMACEUTICALS, INC.
CIK 0001325879
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001644965
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 4:36 PM ET
- Size
- 6.4 KB